ROCHESTER, N.Y. — The Genesee Keg Tree has been named as Newsweek’s “Best Christmas Tree 2026.” Newsweek selected 15 finalists for the Best Christmas Tree 2026. Readers voted for ten standout ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Christmas tree supply is expected to remain steady. With the most wonderful time of the year around the corner, it may be worth it to consider buying a real tree to hide presents under this year. With ...

Moving beyond using artificial intelligence to write lesson plans and crafts emails to parents, educators are seeking out opportunities to use AI in ways that move learning forward. In this middle ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

The US Senate Agriculture Committee has released its long-awaited discussion draft of crypto market structure laws, bringing Congress closer to passing legislation outlining how the crypto sector will ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

The Rockefeller Center Christmas tree will again be from upstate New York this holiday season. A 75-foot-tall, 45-foot-diameter Norway spruce from East Greenbush, Rensselaer County, will be heading ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Recursion ...

Harvard University confirmed that it fell victim to an attack exploiting the recently disclosed zero-day vulnerability in Oracle's E-Business Suite (EBS) system. The critical vulnerability, tracked as ...

You’re reading State of Crypto, a CoinDesk newsletter looking at the intersection of cryptocurrency and government. Click here to sign up for future editions. Policy work around digital assets seems ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...